Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Aceso Life Science GroupHKSE:00474 19 EV-to-FCF is 16.46 as of Aug. 12, 2026, which is 411% above its 10-year median of 3.22. GuruFocus rates HKSE:00474 with a GF Score™ of 19/100 and a GF Value™ of HK$0.08 (Significantly Overvalued). The stock has 8 warning signs investors should review. Among 719 Business Services companies, Aceso Life Science Group ranks worse than 61.34% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Aceso Life Science Group's Enterprise Value is HK$1,908.8 Mil.
Aceso Life Science Group's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2025 was HK$116.0 Mil. Therefore, Aceso Life Science Group's EV-to-FCF for today is 16.46.
The historical rank and industry rank for Aceso Life Science Group's EV-to-FCF or its related term are showing as below:
HKSE:00474'
s EV-to-FCF Range Over the Past 10 Years
Min: -90.16 Med: 3.22 Max: 248.85
Current: 16.46
During the past 13 years, the highest EV-to-FCF of Aceso Life Science Group was 248.85. The lowest was -90.16. And the median was 3.22.
HKSE:00474's EV-to-FCF is ranked worse than 61.34% of 719
companies
in the Business Services industry
Industry Median: 13
vs HKSE:00474: 16.46
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Aceso Life Science Group (HKSE:00474) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Aceso Life Science Group's PE Ratio (TTM) for today is calculated as:
Aceso Life Science Group's share price for today is HK$0.114.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Aceso Life Science Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2025 was HK$-0.052.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Aceso Life Science Group EV-to-FCF Related Terms
Aceso Life Science Group EV-to-FCF Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:00474 vs URI, SUNB, AER: EV-to-FCF Comparison
For the Rental & Leasing Services subindustry, Aceso Life Science Group's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aceso Life Science Group EV-to-FCF vs Business Services Industry
For the Business Services industry and Industrials sector, Aceso Life Science Group's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Aceso Life Science Group's EV-to-FCF falls into.
Aceso Life Science Group's current Enterprise Value is HK$1,908.8 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Aceso Life Science Group's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2025 was HK$116.0 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aceso Life Science Group (HKSE:00474) has a EV-to-FCF of 16.46 as of Aug. 12, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Aceso Life Science Group and its competitors. This is 411% above median its historical median of 3.22. According to the industry distribution chart, Aceso Life Science Group ranks #441 out of 719 companies in the Business Services industry, placing it in the top 61.3%.
Is Aceso Life Science Group's EV-to-FCF too high?
Aceso Life Science Group's current EV-to-FCF of 16.46 is 411% above median its 10-year median of 3.22. The Business Services industry median EV-to-FCF is 13.00. Aceso Life Science Group's value of 16.46 is 26.6% above this industry median. Based on the distribution chart, Aceso Life Science Group ranks #441 out of 719 companies in the Business Services industry, which is below the industry midpoint. Overall, Aceso Life Science Group has a GF Score™ of 19/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Aceso Life Science Group's EV-to-FCF compare to URI and SUNB?
According to the Business Services industry distribution chart, Aceso Life Science Group ranks #441 out of 719 companies for EV-to-FCF. This places Aceso Life Science Group in the lower half of its industry. The industry median EV-to-FCF is 13.00. Aceso Life Science Group's value of 16.46 is 26.6% above this benchmark. While the company's 10-year median is 3.22 vs. the industry median of 13.00, Aceso Life Science Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Business Services company?
The median EV-to-FCF among Business Services companies is 13.00, based on 719 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Aceso Life Science Group's current EV-to-FCF of 16.46 is 26.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Aceso Life Science Group and its competitors. For the Business Services industry, the median EV-to-FCF is 13.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aceso Life Science Group's current EV-to-FCF is 16.46, which is 411% above median its own 10-year median of 3.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aceso Life Science Group stock overvalued right now?
Based on GuruFocus' analysis, Aceso Life Science Group (HKSE:00474) is currently considered Significantly Overvalued. The stock's GF Value™ is HK$0.08, compared to a current price of HK$0.11 — trading 42.5% above its estimated fair value. The current EV-to-FCF is 16.46, which is 411% above median its 10-year median of 3.22 and 26.6% above the Business Services industry median of 13.00. Aceso Life Science Group's overall GF Score™ is 19/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Aceso Life Science Group (HKSE:00474), the current EV-to-FCF is 16.46 as of Aug. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Aceso Life Science Group (HKSE:00474) Overvalued in 2026?
Based on GuruFocus' analysis, Aceso Life Science Group stock appears to be overvalued.
The current stock price of HK$0.11 is trading 42.5% above its estimated GF Value™ of HK$0.08.
GuruFocus considers Aceso Life Science Group to be Significantly Overvalued.
Key valuation signals for HKSE:00474:
EV-to-FCF: 16.46 (411% above median its 10-year median of 3.22)
GF Value™: HK$0.08 vs. price of HK$0.11 (42.5% above fair value)
Industry Position: 26.6% above the Business Services median (#441 of 719)
No single metric tells the full story. See the HKSE:00474 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Aceso Life Science Group Ltd is an investment holding company. The group's operating segments include Money lending, Rental and sale of construction machinery and spare parts business, Provision of repair and maintenance and transportation service business, Provision of asset management, securities brokerage, commodities, futures, and other financial service business, Property leasing business, and Property development business. It derives key revenue from the rental and sale of construction machinery and spare parts. Geographically, the group has a business presence in Hong Kong, the UK, the PRC, Macau, and Cambodia.
19GF Score
Get the complete analysis for HKSE:00474
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:00474 has been successfully added to your 
